Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands.
Oishi. Shinya S; Misu. Ryosuke R; Tomita. Kenji K; Setsuda. Shohei S; Masuda. Ryo R; Ohno. Hiroaki H; Naniwa. Yousuke Y; Ieda. Nahoko N; Inoue. Naoko N; Ohkura. Satoshi S; Uenoyama. Yoshihisa Y; Tsukamura. Hiroko H; Maeda. Kei-Ichiro K; Hirasawa. Akira A; Tsujimoto. Gozoh G; Fujii. Nobutaka N
Key Findings
- Kisspeptin-10 binds and activates NPFFR1 and NPFFR2 with high potency
- Shorter kisspeptin peptides have much lower affinity for NPFF receptors and stay more selective for GPR54
- NPFFR ligands show negligible binding to GPR54, indicating one‑way cross‑reactivity
Practical Outcomes
- If you’re experimenting with kisspeptin‑10, expect possible off‑target effects on NPFF pathways that could influence pain perception, feeding behavior, or hormone release. Using shorter kisspeptin analogs may reduce these side effects and give a cleaner GPR54‑focused effect.
Summary
Kisspein-10 not only hits its main target (the GPR54 receptor that controls reproductive hormones) but also strongly activates a different set of receptors called NPFFR1 and NPFFR2, which are involved in things like pain and appetite. Shorter kisspein fragments are more selective and don’t hit those side receptors as much.
Abstract
Kisspeptin is a member of the RFamide neuropeptide family that is implicated in gonadotropin secretion. Because kisspeptin-GPR54 signaling is implicated in the neuroendocrine regulation of reproduction, GPR54 ligands represent promising therapeutic agents against endocrine secretion disorders. In the present study, the selectivity profiles of GPR54 agonist peptides were investigated for several GPCRs, including RFamide receptors. Kisspeptin-10 exhibited potent binding and activation of neuropeptide FF receptors (NPFFR1 and NPFFR2). In contrast, short peptide agonists bound with much lower affinity to NPFFRs while showing relatively high selectivity toward GPR54. The possible localization of secondary kisspeptin targets was also demonstrated by variation in the levels of GnRH release from the median eminence and the type of GPR54 agonists used. Negligible affinity of the reported NPFFR ligands to GPR54 was observed and indicates the unidirectional cross-reactivity between both ligands.
Study Information
pubmed
2010
2010-10-25T00:00:00.000Z
10.1021/ml1002053
89
31